FDA Risk Communication Panel Critiques MedWatch, And MedWatcher App
This article was originally published in The Gray Sheet
Executive Summary
Promotion of the consumer MedWatch form and the newly released MedWatcher adverse event reporting app needs to be improved if more physicians and consumers are to use it, FDA’s Risk Communication Advisory Committee says.